Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) EBIT Margin (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed EBIT Margin for 6 consecutive years, with 9.59% as the latest value for Q4 2025.

  • Quarterly EBIT Margin rose 663.0% to 9.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.18% through Dec 2025, up 806.0% year-over-year, with the annual reading at 11.34% for FY2025, 400.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 9.59% at Strata Critical Medical, up from 11.4% in the prior quarter.
  • The five-year high for EBIT Margin was 7.0% in Q2 2025, with the low at 75.05% in Q4 2023.
  • Average EBIT Margin over 5 years is 29.9%, with a median of 21.41% recorded in 2022.
  • The sharpest move saw EBIT Margin tumbled -4596bps in 2021, then surged 5883bps in 2024.
  • Over 5 years, EBIT Margin stood at 42.8% in 2021, then dropped by -21bps to 51.6% in 2022, then crashed by -45bps to 75.05% in 2023, then skyrocketed by 78bps to 16.23% in 2024, then surged by 41bps to 9.59% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 9.59%, 11.4%, and 7.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.